期刊文献+

胃癌前病变的干预及中医药治疗 被引量:15

Intervention and Chinese Medicine treatment on gastric precancerous lesions
下载PDF
导出
摘要 胃癌前病变是一个病理学概念,通常包括肠上皮化生和异型增生,是正常胃黏膜向胃癌转化过程中的一个重要阶段。胃癌前病变的干预是胃癌防治研究的关键领域,现代医学对胃癌前病变的研究取得了一定的成果,但尚未显示有突破性进展。众多的临床报道证实,中医药对治疗胃癌前病变具有优势性疗效,能够在改善患者的临床症状的同时,使部分肠上皮化生和异性增生减轻甚至消失,改变了胃癌前病变难以逆转的传统观点,使胃癌的二级预防成为可能。 Gastric precancerous lesions,being a pathological concept,included intestinal metaplasia and dysplasia,and it was an important stage of the transformation from normal gastric mucosa to gastric cancer. Intervention of gastric precancerous lesions was the main area of gastric cancer prevention study. Modern medicine has made certain progress on the study of the precancerous lesions of gastric cancer,but it has not shown any breakthroughs. Many clinical studies have shown that traditional Chinese medicine has advantageous effect on gastric precancerous lesions. It can improve the clinical symptoms of patients,while reducing and even evanishing the intestinal metaplasia and dysplasia. Traditional Chinese medicine treatment has changed the traditional view that the reversal of gastric precancerous lesions is difficult,making the secondary prevention of gastric cancer possible.
作者 孙心 陈涤平
出处 《长春中医药大学学报》 2015年第2期289-293,共5页 Journal of Changchun University of Chinese Medicine
关键词 胃癌前病变 肠上皮化生 异性增生 中医药疗法 gastric precancerous lesions intestinal metaplasia dysplasia traditional Chinese medicine treatment
  • 相关文献

参考文献30

  • 1CORREA P.Human gastric carcinogenesis:a multistep and multifactorial process—first American Cancer Society award lecture on cancer epidemiology and prevention[J].Cancer research,1992,52(24):6735-6740.
  • 2DIXON M F.Gastrointestinal epithelial neoplasia:Vienna revisited[J].Gut,2002,51(1):130-131.
  • 3CORREA P,PIAZUELO M B,WILSON K T.Pathology of gastric intestinal metaplasia:clinical implications[J].The American journal of gastroenterology,2010,105(3):493.
  • 4中国慢性胃炎共识意见[J].现代消化及介入诊疗,2007,12(1):55-62. 被引量:214
  • 5CORREA P,FONTHAM E T H,BRAVO J C,et al.Chemoprevention of gastric dysplasia:randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy[J].Journal of the National Cancer Institute,2000,92(23):1881-1888.
  • 6MAHATA Y,NAKAMURA S,FUJISAWA K,et al.Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer[J].Gastrointestinal endoscopy,2012,75(1):39-46.
  • 7SASAZUKI S,HAYASHI T,NAKACHI K,et al.Protective effect of vitamin C on oxidative stress:a randomized controlled trial[J].International Journal for Vitamin and Nutrition Research,2008,78(3):121-128.
  • 8GONDA T A,KIM Y I,SALAS M C,et al.Folic acid increases global DNA methylation and reduces inflammation to prevent Helicobacter-associated gastric cancer in mice[J].Gastroenterology,2012,142(4):824-833.
  • 9YANAOKA K,OKA M,YOSHIMURA N,et al.Preventive effects of etodolac,a selective cyclooxygenase-2 inhibitor,on cancer development in extensive metaplastic gastritis,a Helicobacter pylori-negative precancerous lesion[J].International Journal of Cancer,2010,126(6):1467-1473.
  • 10黄昌明,陆俊.胃癌癌前病变的诊断和处理[J].中国实用外科杂志,2014,34(1):30-32. 被引量:11

二级参考文献145

共引文献443

同被引文献213

引证文献15

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部